Innovative Medicines Canada, one of the CCTCC’s funding organizations, welcomes Pamela Fralick as President of the association effective today.

Ms. Fralick comes to Innovative Medicines Canada as a proven healthcare leader, with a wealth of experience advancing critical healthcare initiatives and a deep understanding of public policy and organizational management sie könnten diese ausprobieren.

For more information on this announcement, please click here.